HYPERION THERAPEUTICS INC — Form D

HYPERION THERAPEUTICS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-14. The offering totals $15.0M, of which $13.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
Don SantelExecutive OfficerSouth San Francisco, CA
Gaurav AggarwalDirectorPalo Alto, CA
Rob HopfnerDirectorSan Diego, CA
James I HealyDirectorDORADO, PR
Robert HopfnerDirectorPalo Alto, CA
James HealyDirectorSunnyvale, CA
CHRISTINE A NASHExecutive OfficerNEW HAVEN, CT
Daniel PerezDirectorSan Francisco, CA
Donald J SantelExecutive OfficerSan Diego, CA
David GryskaDirectorDallas, TX
Donald SantelDirectorSan Diego, CA
Donald SantelExecutive OfficerSan Diego, CA
Bijan SalehizadehDirectorBETHESDA, MD
Jake NunnDirectorMenlo Park, CA
Jake R NunnDirectorSan Diego, CA
Bijan R SalehizadehDirectorChicago, IL
Bo Jesper HansenDirectorWestlake Village, CA
Lota S ZothDirectorLa Jolla, CA
Bo Jesper I HansenDirectorBrisbane, CA
Natalie A HollesExecutive OfficerBrisbane, CA
Daniel G WelchDirectorBrisbane, CA
Ashley A GouldExecutive OfficerBrisbane, CA
Klara A DickinsonExecutive OfficerBrisbane, CA
Bruce F ScharschmidtExecutive OfficerBrisbane, CA
Jeffrey S FarrowExecutive OfficerBrisbane, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2014-06-18D$8.0M$8.0M
2011-11-04D$15.0M$7.5M
2011-04-18D$35.0M$17.5M
2009-07-16D$45.5M$22.0M

More